OTTYSHA WHITE: Open Payments
NPI 1255584637 · BROOKLAND, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 33 payments from 8 companies in 2025. Trend: 2023 $562 · 2024 $233 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $208 |
| ABBVIE INC. | 5 | $154 |
| Axsome Therapeutics, Inc. | 4 | $115 |
| Janssen Pharmaceuticals, Inc | 4 | $88 |
| Neurocrine BioSciences, Inc. | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Indivior Inc. | 1 | $27 |
Products named: ARISTADA, VRAYLAR, Auvelity, INGREZZA, SPRAVATO, INVEGA SUSTENNA, COBENFY, HETLIOZ.
Industry payments across AR — which companies pay providers there.
